David Spetzler's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 13,856 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.25 per share. | 15 May 2026 | 13,856 | 530,083 | - | 15.3 | 211,304 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 83,162 | 543,939 | - | 0 | Common Stock | |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Purchase of securities on an exchange or from another person at price $ 23.85 per share. | 07 Nov 2025 | 400 | 460,777 | - | 23.9 | 9,540 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. | 11 Aug 2025 | 63,509 | 460,377 | - | 29.8 | 1,889,393 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 750,000 | 750,000 | - | - | Stock Option | |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Sale or transfer of securities back to the company at price $ 18.60 per share. | 03 Mar 2025 | 700,509 | 351,240 | - | 18.6 | 13,029,467 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 132,428 | 483,668 | - | 0 | Common Stock | |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 75,000 | 0 | - | - | Stock Option | |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. | 03 Mar 2025 | 75,000 | 558,668 | - | 2.4 | 183,000 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Spetzler | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.25 per share. | 03 Mar 2025 | 34,782 | 523,886 | - | 27.3 | 947,810 | Common Stock |